You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

CLINICAL TRIALS PROFILE FOR BELIMUMAB

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for belimumab

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00071487 ↗	Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)	Completed	Human Genome Sciences Inc.	Phase 2	2003-10-01	The purpose of this study is to evaluate the safety and efficacy of 3 different doses of belimumab, administered in addition to standard therapy, in patients with active SLE disease.
NCT00071812 ↗	A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)	Completed	Human Genome Sciences Inc.	Phase 2	2003-12-01	The purpose of this study is to evaluate the safety and efficacy of 3 different doses of belimumab, administered in addition to standard therapy, in patients with rheumatoid arthritis (RA).
NCT00410384 ↗	A Study of Belimumab in Subjects With Systemic Lupus Erythematosus	Completed	GlaxoSmithKline	Phase 3	2006-12-01	The purpose of this study is to evaluate the efficacy, safety, tolerability, and impact on quality of life of two different doses of belimumab administered in addition to standard therapy in subjects with active, autoantibody-positive systemic lupus erythematosus (SLE) disease.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for belimumab

Condition Name

Chart
Table

Condition Name for belimumab
Intervention	Trials
Systemic Lupus Erythematosus	21
Lupus Erythematosus, Systemic	4
Sjogren's Syndrome	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for belimumab
Intervention	Trials
Lupus Erythematosus, Systemic	26
Syndrome	4
Vasculitis	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for belimumab

Trials by Country

Map
Table

Trials by Country for belimumab
Location	Trials
United States	263
Germany	40
China	29
Brazil	29
Canada	23
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for belimumab
Location	Trials
New York	17
California	13
Alabama	13
Ohio	13
Texas	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for belimumab

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for belimumab
Clinical Trial Phase	Trials
Phase 4	6
Phase 3	13
Phase 2/Phase 3	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for belimumab
Clinical Trial Phase	Trials
Completed	30
Recruiting	14
Not yet recruiting	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for belimumab

Sponsor Name

Chart
Table

Sponsor Name for belimumab
Sponsor	Trials
GlaxoSmithKline	40
Human Genome Sciences Inc.	13
Human Genome Sciences Inc., a GSK Company	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for belimumab
Sponsor	Trials
Industry	65
Other	42
NIH	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.